Gene · 1902
Papers2,112
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,112
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mannose-modified exosomes loaded with MiR-23b-3p target alveolar macrophages to alleviate acute lung injury in Sepsis. | J Control Release | 2025 | 39870316 | PubTator, text mining | PubMed |
| Molecular mechanism of ligand recognition and activation of lysophosphatidic acid receptor LPAR6. | Proc Natl Acad Sci U S A | 2025 | 39847322 | PubTator, text mining | PubMed |
| Targeting the Hippo and Rap1 signaling pathways: the anti-proliferative effects of curcumin in colorectal cancer cell lines. | Med Oncol | 2025 | 39779534 | PubTator, text mining | PubMed |
| Structural insights into the engagement of lysophosphatidic acid receptor 1 with different G proteins. | J Struct Biol | 2025 | 39725093 | PubTator, text mining | PubMed |
| LPA reduces the apoptosis of cryopreserved porcine skin-derived stem cells by inhibiting the regulatory factor TNF-α. | Cryobiology | 2025 | 39706283 | PubTator, text mining | PubMed |
| Cellular responses to low nutrient conditions via activation of lysophosphatidic acid (LPA) receptor signaling in gastric cancer cells. | Adv Biol Regul | 2025 | 39626328 | PubTator, text mining | PubMed |
| Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial. | Am J Respir Crit Care Med | 2025 | 39393084 | PubTator, text mining | PubMed |
| LPA suppresses HLA-DR expression in human melanoma cells: a potential immune escape mechanism involving LPAR1 and DR6-mediated release of IL-10. | Acta Pharmacol Sin | 2025 | 39187677 | PubTator, text mining | PubMed |
| Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis. | Pharm Sci Adv | 2024 | 41550179 | PubTator, text mining | PubMed |
| Prognostic value of nomogram model based on clinical risk factors and CT radiohistological features in hypertensive intracerebral hemorrhage. | Front Neurol | 2024 | 39697438 | PubTator, text mining | PubMed |
| The Effects of Dexamethasone on Human Lens Epithelial Cells and the Analysis of Related Pathways with Transcriptome Sequencing. | Front Biosci (Landmark Ed) | 2024 | 39614453 | PubTator, text mining | PubMed |
| Identification of biomarkers for the diagnosis in colorectal polyps and metabolic dysfunction-associated steatohepatitis (MASH) by bioinformatics analysis and machine learning. | Sci Rep | 2024 | 39604470 | PubTator, text mining | PubMed |
| MicroRNA-429 overexpression overcomes imatinib resistance of glioma cells by negatively regulating lysophosphatidic acid receptor 1. | Neurol Res | 2024 | 39531542 | PubTator, text mining | PubMed |
| YAP mediates HIV-related liver fibrosis. | JHEP Rep | 2024 | 39524207 | PubTator, text mining | PubMed |
| Structural mechanisms of potent lysophosphatidic acid receptor 1 activation by nonlipid basic agonists. | Commun Biol | 2024 | 39506093 | PubTator, text mining | PubMed |
| COADREADx: A comprehensive algorithmic dissection of colorectal cancer unravels salient biomarkers and actionable insights into its discrete progression. | PeerJ | 2024 | 39484215 | PubTator, text mining | PubMed |
| Insights into autotaxin- and lysophosphatidate-mediated signaling in the pancreatic ductal adenocarcinoma tumor microenvironment: a survey of pathway gene expression. | Am J Cancer Res | 2024 | 39267662 | PubTator, text mining | PubMed |
| Downregulation of LPAR1 Promotes Invasive Behavior in Papillary Thyroid Carcinoma Cells. | Cancer Inform | 2024 | 39253536 | PubTator, text mining | PubMed |
| Lysophospholipid receptors in neurodegeneration and neuroprotection. | Explor Neuroprotective Ther | 2024 | 39247084 | PubTator, text mining | PubMed |
| The role of LPA receptor signaling in modulating cellular responses of colon cancer cells co-cultured with lymphoid endothelial cells under hypoxic stress. | Tissue Cell | 2024 | 39208538 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1902/papers?page=5